Additionally, TNF-α interacts with SGLT2 (sodium-glucose cotransporter 2), promoting vascular inflammation and endothelial dysfunction via the NADPH oxidase-angiotensin II pathway, thereby accelerating atherosclerosis (Mroueh et al., 2024). Here, FMO5 is linked to atherosclerosis.